Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis

P. H. Plotz, J. H. Klippel, J. L. Decker, D. Grauman, B. Wolff, B. C. Brown, G. Rutt

Research output: Contribution to journalArticle

Abstract

The bladder complications of 54 patients treated with oral cyclophosphamide for systemic lupus erythematosus (43) or rheumatoid arthritis (11) were reviewed. During an observation period of 241 patient years, we saw 7 cases of acute hemorrhagic cystitis and 2 cases of transitional cell carcinoma of the bladder. Bladder carcinoma was identified 28 and 60 months after withdrawal of the drug and resulted in the death of one patient. The late-occurring serious toxicities of cyclophosphamide should limit the use of the drug in the treatment of nonmalignant inflammatory rheumatic conditions.

Original languageEnglish (US)
Pages (from-to)221-223
Number of pages3
JournalAnnals of Internal Medicine
Volume91
Issue number2
StatePublished - 1979
Externally publishedYes

Fingerprint

Systemic Lupus Erythematosus
Cyclophosphamide
Rheumatoid Arthritis
Urinary Bladder
Cystitis
Transitional Cell Carcinoma
Pharmaceutical Preparations
Observation
Carcinoma
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Plotz, P. H., Klippel, J. H., Decker, J. L., Grauman, D., Wolff, B., Brown, B. C., & Rutt, G. (1979). Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis. Annals of Internal Medicine, 91(2), 221-223.

Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis. / Plotz, P. H.; Klippel, J. H.; Decker, J. L.; Grauman, D.; Wolff, B.; Brown, B. C.; Rutt, G.

In: Annals of Internal Medicine, Vol. 91, No. 2, 1979, p. 221-223.

Research output: Contribution to journalArticle

Plotz, PH, Klippel, JH, Decker, JL, Grauman, D, Wolff, B, Brown, BC & Rutt, G 1979, 'Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis', Annals of Internal Medicine, vol. 91, no. 2, pp. 221-223.
Plotz, P. H. ; Klippel, J. H. ; Decker, J. L. ; Grauman, D. ; Wolff, B. ; Brown, B. C. ; Rutt, G. / Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis. In: Annals of Internal Medicine. 1979 ; Vol. 91, No. 2. pp. 221-223.
@article{0082cf22231b4d9297a2442397d00091,
title = "Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis",
abstract = "The bladder complications of 54 patients treated with oral cyclophosphamide for systemic lupus erythematosus (43) or rheumatoid arthritis (11) were reviewed. During an observation period of 241 patient years, we saw 7 cases of acute hemorrhagic cystitis and 2 cases of transitional cell carcinoma of the bladder. Bladder carcinoma was identified 28 and 60 months after withdrawal of the drug and resulted in the death of one patient. The late-occurring serious toxicities of cyclophosphamide should limit the use of the drug in the treatment of nonmalignant inflammatory rheumatic conditions.",
author = "Plotz, {P. H.} and Klippel, {J. H.} and Decker, {J. L.} and D. Grauman and B. Wolff and Brown, {B. C.} and G. Rutt",
year = "1979",
language = "English (US)",
volume = "91",
pages = "221--223",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "2",

}

TY - JOUR

T1 - Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis

AU - Plotz, P. H.

AU - Klippel, J. H.

AU - Decker, J. L.

AU - Grauman, D.

AU - Wolff, B.

AU - Brown, B. C.

AU - Rutt, G.

PY - 1979

Y1 - 1979

N2 - The bladder complications of 54 patients treated with oral cyclophosphamide for systemic lupus erythematosus (43) or rheumatoid arthritis (11) were reviewed. During an observation period of 241 patient years, we saw 7 cases of acute hemorrhagic cystitis and 2 cases of transitional cell carcinoma of the bladder. Bladder carcinoma was identified 28 and 60 months after withdrawal of the drug and resulted in the death of one patient. The late-occurring serious toxicities of cyclophosphamide should limit the use of the drug in the treatment of nonmalignant inflammatory rheumatic conditions.

AB - The bladder complications of 54 patients treated with oral cyclophosphamide for systemic lupus erythematosus (43) or rheumatoid arthritis (11) were reviewed. During an observation period of 241 patient years, we saw 7 cases of acute hemorrhagic cystitis and 2 cases of transitional cell carcinoma of the bladder. Bladder carcinoma was identified 28 and 60 months after withdrawal of the drug and resulted in the death of one patient. The late-occurring serious toxicities of cyclophosphamide should limit the use of the drug in the treatment of nonmalignant inflammatory rheumatic conditions.

UR - http://www.scopus.com/inward/record.url?scp=0018696672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018696672&partnerID=8YFLogxK

M3 - Article

C2 - 464465

AN - SCOPUS:0018696672

VL - 91

SP - 221

EP - 223

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 2

ER -